1. Home
  2. OMH vs SNGX Comparison

OMH vs SNGX Comparison

Compare OMH & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.80

Market Cap

17.6M

Sector

Finance

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.45

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMH
SNGX
Founded
2015
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
13.8M
IPO Year
2023
1987

Fundamental Metrics

Financial Performance
Metric
OMH
SNGX
Price
$0.80
$1.45
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
43.0K
454.3K
Earning Date
04-17-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,264,748.00
N/A
Revenue This Year
$28.40
N/A
Revenue Next Year
$23.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
78.86
N/A
52 Week Low
$0.59
$1.09
52 Week High
$5.10
$6.23

Technical Indicators

Market Signals
Indicator
OMH
SNGX
Relative Strength Index (RSI) 41.45 50.04
Support Level $0.80 $1.31
Resistance Level $0.87 $1.70
Average True Range (ATR) 0.08 0.12
MACD 0.00 -0.01
Stochastic Oscillator 18.05 54.55

Price Performance

Historical Comparison
OMH
SNGX

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: